Robuta

https://collections.nlm.nih.gov/catalog/nlm:nlmuid-101435490-img [Patent Medicines: Advertisement for pain killer for cholera] - Digital Collections - National... patent medicines for pain digital collections advertisement killer https://cordis.europa.eu/programme/id/FP7_HEALTH.2010.4.2-1 Off-Patent Medicines for Children. FP7-HEALTH-2010-single-stage | Programme | FP7 | CORDIS |... medicines for children https://medicinespatentpool.org/ MPP Home - The Medicines Patent Pool the medicines mpp patent pool https://www.undp.org/latin-america/publications/methodology-patent-searches-essential-medicines-developing-countries A Methodology for Patent Searches on Essential Medicines in Developing Countries | United Nations... The main aim of the present document is twofold; first, to set out the technical aspects of the rationale for the Methodology; and second, to describe how it... https://cordis.europa.eu/programme/id/FP7_HEALTH.2013.4.2-1/pl Investigator-driven clinical trials for off-patent medicines using innovative, age-appropriate... clinical trials https://pubchem.ncbi.nlm.nih.gov/patent/EP-0040144-B1 Sulfated polysaccharides, process for their preparation and their use as medicines - Patent... EP-0040144-B1 chemical patent summary. polysaccharides process https://hsrc.himmelfarb.gwu.edu/sphhs_policy_facpubs/932/ "Moderating the impact of patent linkage on access to medicines: lesson" by Kyung-Bok Son, Ruth... By Kyung-Bok Son, Ruth Lopert, Deborah Gleeson, et al., Published on 10/24/18 https://legalblogs.wolterskluwer.com/patent-blog/final-building-handed-over-to-european-medicines-agency-in-amsterdam/ Final building handed over to European Medicines Agency in Amsterdam | Kluwer Patent Blog The Dutch authorities have handed over to the European Medicines Agency (EMA) its new premises, located in the Zuidas business area of Amsterdam. On 15... european medicines agency https://www.canada.ca/en/health-canada/services/canada-access-medicines-regime/companies/forms/declare-identity-patent-status-pharmaceutical-product.html Declare identity and patent status of pharmaceutical product under Canada's Access to Medicines... Instructions for determining which sub-section of Paragraph 21 of the Patent Act to use when completing a declaration.